Breeze Medical
Breeze Medical
Engineered specifically for low-binding, endotoxin-free, and beta-glucan assay contamination-resistant workflows.
Ningbo Breeze Medical Co., Ltd., founded in 2011, has established itself as a leader in the medical device industry, specializing in the manufacturing of disposable medical consumables and laboratory instruments.
Committed to providing the highest quality products, the company has invested in state-of-the-art infrastructure, including a cleanroom, an automatic injection molding workshop, and a support production line that meets the strictest GMP (Good Manufacturing Practice) standards. In addition, the company has set up a Product Quality Testing Center to ensure the reliability and performance of all its products.
Through systematic quality engineering, Ningbo Breeze Medical bridges the critical gap between high-precision analytical assay chemistry—such as (1→3)-β-D-glucan assays—and high-volume, contamination-free polymer manufacturing.
The critical role of substrate neutrality, pyrogen-free consumables, and photometrical transparency in Invasive Fungal Infection (IFI) diagnostics.
(1→3)-β-D-glucan (BDG) is a major cell wall component of most pathogenic fungi (including Candida, Aspergillus, and Pneumocystis jirovecii). BDG activates Factor G in horseshoe crab amebocyte lysates, triggering a coagulation enzyme cascade. Because this reaction is sensitive to picogram concentrations, non-specific plasticizer leaching or environmental dust artifacts can compromise results.
Common false positives stem from cotton-derived cellulose filters, fungal spore fallout, and standard laboratory plastics containing glucan-based molding release agents. Breeze Medical deploys high-grade virgin polypropylene resins, paired with mold surface electric discharge machining (EDM), guaranteeing chemically inert consumables free from external Factor G reactives.
Modern chromogenic and turbidimetric kinetic assays require microplates and reaction tubes with optimal spectrophotometric precision at 405nm and 545nm wavelengths. Breeze Medical’s multi-cavity injection molds produce microcentrifuge tubes and deep-well plates that minimize meniscus variation and light-path refraction, preserving linear optical density gradients.
Scalable, fully automated production systems designed for clinical diagnostic reliability and high throughput.
The company has developed a cutting-edge processing capacity that allows it to manufacture products in large volumes without compromising on quality. Its modern production infrastructure includes advanced equipment that optimizes efficiency and precision in the manufacturing process. Additionally, the company has implemented automated production lines that ensure consistent quality and the ability to meet global market demands.
Among the company’s flagship systems and specialized processing hardware are:
High-frequency degreasing and surface cleansing lines that ensure multi-cavity molds and plastic components remain devoid of sub-micron particulate residues.
Automated thermal and barcode printing units for cryo-resistant, solvent-resistant tracking labels on diagnostic vials and centrifuge vessels.
Micro-dosing systems designed for exact, air-bubble-free filling of separation gels and diagnostic reagents under cleanroom atmospheric controls.
High-tonnage, all-electric high-speed injection molders operating in Class 100,000 cleanrooms to eliminate hydraulic oil vapor contaminations.
HEPA-filtered convection ovens for complete solvent and moisture purge cycles on heat-resistant diagnostic substrate formulations.
Robotic multi-step assembly platforms incorporating tube molding, ultrasonic sealing, gasket seating, and sterile pouch packaging without human contact.
Turnkey robotic line providing chemical additive spraying (EDTA, clot activators, heparin), vacuum stabilization, rubber stopper capping, and barcode indexing at high output rates.
Optimized consumable integration across clinical medicine, industrial fermentation, and food verification.
Critically ill, neutropenic, and post-transplant patients are vulnerable to life-threatening candidaemia and invasive aspergillosis. Breeze Medical’s ultra-pure vacuum collection tubes and low-retention pipette tips reduce false positives, enabling early anti-fungal intervention.
In recombinant therapeutic protein and monoclonal antibody manufacturing, microbial cell wall contaminants can trigger immune responses. Our deep-well microplates and automated conductive tips streamline high-volume in-process testing without introducing particulate residues.
Mushroom and yeast-derived (1→3)(1→6)-β-glucan extracts are utilized for immune support therapies. Our cell culture inserts and microcentrifuge platforms provide repeatable validation protocols to differentiate bio-active beta-glucans from inactive starch adulterants.
Benchmarking Breeze Medical's engineered lab consumables against standard commercial offerings.
| Performance Characteristic | Ningbo Breeze Medical Standard | Standard Market Competitor | Assay Quality Impact |
|---|---|---|---|
| Bacterial Endotoxin / BDG Residual | < 0.005 EU/mL (Batch Tested via LAL/TAL) | < 0.05 EU/mL or Non-Specified | Prevents false-positive activation of Factor G cascade in clinical assays. |
| Raw Polymer Selection | Medical-grade pure polypropylene (FDA USP Class VI) | Recycled regrind blends or commercial plastics | Eliminates polymer leachables that absorb at 405nm optical bands. |
| Surface Hydrophobicity & Binding | Liquid slip-angle < 15° with ultra-low protein binding | Standard non-treated polypropylene (angle > 45°) | Prevents analyte wall-adsorption, preserving assay kinetics. |
| Sterilization Assurance Level (SAL) | SAL 10⁻⁶ via validated Electron Beam or EO processing | SAL 10⁻³ or uncontrolled gamma irradiation | Guarantees zero viable fungal spores, yeast remnants, or RNase/DNase. |
| Automated Dimensional Tolerance | ±0.02mm via robotic machine-vision QC cameras | ±0.15mm standard manual caliper sampling | Avoids robotic arm jamming in high-throughput automated liquid handlers. |
Since its inception, Ningbo Breeze Medical has adhered to a business philosophy centered around quality and innovation. The company follows a stringent quality management and control system that complies with international standards, ensuring that its products are reliable and safe for use in various medical applications.
As a result, Breeze Medical has earned prestigious certifications such as ISO 9001:2008, ISO 13485:2003, and CE, assuring that its products meet global quality and safety standards.
Ningbo Breeze Medical Co., Ltd. has significantly expanded its presence in both domestic and international markets. Its products are widely available and in high demand across various countries, reflecting the growing trust in the brand. The company’s success in global markets demonstrates its ability to offer innovative, high-quality products to customers worldwide.
Strategically positioned adjacent to Ningbo Port—one of the world's largest container shipping hubs—our integrated manufacturing infrastructure ensures stable maritime transport, low freight costs, and predictable multi-container delivery schedules.
Anticipating next-generation molecular biology and synthetic biomarker testing needs.
Miniaturization of the Limulus/Tachypleus amebocyte lysate reaction into molded COC (cyclic olefin copolymer) cartridges, reducing precious natural reagent requirements by up to 80% while delivering sample-to-answer turnaround within 15 minutes.
Investigating certified bio-attributed polypropylenes that maintain USP Class VI medical purity and ultra-low background fluorescence while mitigating the carbon footprint of disposable labware in high-volume research hospitals.
Developing specialized consumable wells and reaction substrates designed for concurrent detection of (1→3)-β-D-glucan, galactomannan, and fungal DNA via isothermal amplification within single sample protocols.
End-to-end technical consultation, regulatory dossier preparation, and custom mold tooling.
Scientific research is a key pillar of Breeze Medical’s innovation. The company continuously invests in developing new technologies and products that contribute to improved healthcare through precision molding, functional resin modifications, and automation.
Breeze Medical boasts a team of highly skilled technical support engineers who provide 24/7 assistance to address any customer inquiries or needs, ensuring professional, timely, and responsive service at all times for international partners.
Our regulatory team supports global distributors and IVD manufacturers with DMF registrations, biocompatibility test data (ISO 10993), Sterility Validation reports, and international certificates of conformity for streamlined market approvals.
Key considerations when sourcing diagnostic consumables and beta-glucan assay systems from China.
Reliable consumables for deep-well extraction, high-speed centrifugation, and micro-sampling pipelines.
